PIII Debt To Equity from 2010 to 2024

PIII Stock  USD 0.24  0.03  14.29%   
P3 Health's Debt To Equity is increasing with very volatile movements from year to year. Debt To Equity is predicted to flatten to 0.72. Debt To Equity is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. View All Fundamentals
 
Debt To Equity  
First Reported
2010-12-31
Previous Quarter
0.76211215
Current Value
0.72
Quarterly Volatility
3.88362797
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 91 M, Interest Expense of 16.8 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 0.0932, Dividend Yield of 0.0 or PTB Ratio of 0.83. PIII financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
  
Check out the analysis of P3 Health Correlation against competitors.

Latest P3 Health's Debt To Equity Growth Pattern

Below is the plot of the Debt To Equity of P3 Health Partners over the last few years. It is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. P3 Health's Debt To Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.08 %10 Years Trend
Very volatile
   Debt To Equity   
       Timeline  

PIII Debt To Equity Regression Statistics

Arithmetic Mean3.10
Coefficient Of Variation125.29
Mean Deviation1.74
Median3.02
Standard Deviation3.88
Sample Variance15.08
Range17.7614
R-Value0.05
Mean Square Error16.21
R-Squared0
Significance0.87
Slope0.04
Total Sum of Squares211.16

PIII Debt To Equity History

2024 0.72
2023 0.76
2022 16.13
2021 0.31
2020 -1.63

About P3 Health Financial Statements

Investors use fundamental indicators, such as P3 Health's Debt To Equity, to determine how well the company is positioned to perform in the future. Although P3 Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Debt To Equity 0.76  0.72 

Currently Active Assets on Macroaxis

When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:
Check out the analysis of P3 Health Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.86)
Revenue Per Share
11.552
Quarterly Revenue Growth
0.152
Return On Assets
(0.12)
Return On Equity
(0.41)
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.